CoChat

The Epidemiology of Generalized Anxiety Disorder

Kessler, Ronald C., Keller, Martin B., Wittchen, Hans-Ulrich · 2001 · Psychiatric Clinics of North America

The DOI matches its Crossref record; 74 of the 76 references it cites were found in a registry or an index.

Abstract

The literature reviewed here is consistent in showing that GAD is a common mental disorder that typically has an early age of onset, a chronic course, and a high degree of comorbidity with other anxiety and mood disorders. Comorbid GAD is often temporally primary, especially in relation to mood disorders, and is associated with an increased risk for the subsequent onset and severity of secondary disorders. The weight of evidence reviewed here argues against the view expressed by early commentators that GAD is better conceptualized as a prodrome, residual, or severity marker of other disorders than as an independent disorder. Focused studies of comorbidity between GAD and major depression, in which comorbidity is high, lead to the same conclusion. The crucial evidence for this conclusion includes the following: 1. Contrary to the findings of clinical studies, GAD in the community does not have a higher comorbidity than do most other anxiety or mood disorders. 2. The symptoms of GAD form an empiric cluster distinct from the symptoms of major depression in studies of symptom profiles. 3. Family studies show distinct aggregation of GAD and major depression. 4. Twin studies show that the environmental determinants of GAD are different from the environmental determinants of major depression. 5. The sociodemographic predictors of GAD in epidemiologic studies are different from the predictors of major depression. 6. The clinical course of GAD is less consistently related to comorbidity than is the course of other anxiety and mood disorders. 7. The impairments associated with GAD are equivalent to, or greater than, those associated with other severely impairing chronic physical and mental disorders. These findings show that the status of GAD as an independent disorder is at least as strongly supported by available evidence as is that of other anxiety or mood disorders. This article also shows that uncertainty remains regarding even the basic epidemiologic characteristics of the GAD syndrome. Lingering concerns about the independence of GAD have conspired to exacerbate this problem by promoting repeated changes in the diagnostic criteria for GAD from the DSM-III to DSM-III-R and to DSM-IV. These successive changes have made it difficult to amass consistent long-term data on the natural history of GAD. Available evidence on the empiric validity of current diagnostic thresholds for GAD raises questions about the requirements, such as whether a 6-month minimum duration and four or more additional psychophysiologic symptoms are optimal for identifying all of the people in the general population who suffer from a clinically significant GAD syndrome. An additional source of potential bias in this regard is that the DSM system requires that anxiety be excessive or unrealistic for a diagnosis of GAD. Interestingly, there is no comparable DSM requirement that dysphoria must be excessive or unrealistic to qualify as major depression. These diagnostic uncertainties make it difficult to gain a clear understanding of the true breadth and depth of the GAD syndrome in the general population. Additional research is needed, ideally from unbiased epidemiologic samples, to resolve these basic uncertainties. The strong comorbidity between GAD and major depression, the fact that most people with this type of comorbidity report that the onset of GAD occurred before the onset of depression, and the fact that temporally primary GAD significantly predicts the subsequent onset of depression and other secondary disorders raise the question of whether early intervention and treatment of primary GAD would effectively prevent the subsequent first onset of secondary anxiety and depression. Unfortunately, little is known about this possibility because, as mentioned earlier, few people with pure GAD seek treatment. Why this is true is unknown. Given the early onset of GAD and its strong effects in predicting the subsequent onset, severity, and persistence of other disorders, efforts are needed to collect epidemiologic data on the reasons for the low rate of help seeking among people with pure GAD and to develop outreach strategies that may correct this situation.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0193-953x(05)70204-5

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 74 references

Research works printed but not linked: 3

  1. Angst, 1991, The natural history of anxiety disorder and generalized anxiety disorder, Acta Psychiatr Scand, 141, 572
  2. Hackett, 2000, Venlofaxine XR in the treatment of anxiety, Acta Psychiatr Scand, 102, 3035
  3. Kessler RC, Mickelson KD, Barber C, et al: The effects of chronic medical conditions on work impairment. In Rossi AS (ed): Caring and Doing for Others: Social Responsibility in the Domain of the Family, Work, and Community. Chicago, University of Chicago Press, in press

Cited by

See all 344

Metadata

Authors
Kessler, R. C., Keller, M. B., & Wittchen, H.-U.
Affiliations
  • Harvard University (US)
  • Max Planck Society (DE)
Venue
Psychiatric Clinics of North America
Publisher
Elsevier BV
Published
2001-03
Volume
24
Issue
1
Pages
19-39
ISSN
0193-953X (ISSN-L)
OpenAlex
W2014183716
Cited by
337
References
76
Citations by year
2026: 8 · 2025: 12 · 2024: 13 · 2023: 6 · 2022: 25 · 2021: 13 · 2020: 5 · 2019: 8 · 2018: 12 · 2017: 13 · 2016: 17 · 2015: 16 · 2014: 18 · 2013: 10 · 2012: 14
FWCI
15.49
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Psychiatric Clinics of North America (publishedVersion)
  • PubMed (publishedVersion)
  • Max Planck Institute for Plasma Physics (submittedVersion)
  • MPG.PuRe (Max Planck Society) (submittedVersion)
Funders
  • National Institutes of Health (2k05mh000507-13)
  • National Institute of Mental Health (K05 MH 00507, R01MH046376, R01 MH46376, R01MH051415, MH58261)
  • National Institute on Drug Abuse (R01 DA1121)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
Keywords
generalized anxiety disorder, comorbidities, major depressive disorder, mood disorders, anxiety disorders, diagnostic criteria, DSM-III-R, DSM-IV, familial aggregation, twin studies, sociodemographic predictors, symptom profiles, chronic course, functional disability, natural history (disease), diagnostic thresholds, age of onset
MeSH terms
Anxiety Disorders, Depressive Disorder, Humans, Severity of Illness Index, Comorbidity, Prevalence, Age of Onset

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Epidemiology of Generalized Anxiety Disorder. https://app.cochat.ai/papers/10.1016/s0193-953x(05)70204-5
The paper
Kessler, R. C., Keller, M. B., & Wittchen, H.-U. (2001). The Epidemiology of Generalized Anxiety Disorder. Psychiatric Clinics of North America. https://doi.org/10.1016/s0193-953x(05)70204-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.